BiomeBank appoints ex-Ellerston Capital CIO and Blackrock North Asia Director as Chair to accelerate commercialisation strategy

BiomeBank appoints Mr Chris Hall as Chair, effective 17 January 2022. Mr Hall brings over 30 years’ experience and impressive track record of investment management across both public and private markets within APAC. BiomeBank’s Series A funding round anticipated to close in early 2022. Formal Therapeutic Goods Association (“TGA”) approval of…

0 Comments